{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:14Z","timestamp":1793196554580,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2008205"],"award-info":[{"award-number":["2020YFC2008205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974134, 82070966, 82171058, 8210041510"],"award-info":[{"award-number":["81974134, 82070966, 82171058, 8210041510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016104","name":"Key Project of Research and Development Plan of Hunan Province","doi-asserted-by":"publisher","award":["2020SK2076"],"award-info":[{"award-number":["2020SK2076"]}],"id":[{"id":"10.13039\/100016104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2021RC3026"],"award-info":[{"award-number":["2021RC3026"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ41021"],"award-info":[{"award-number":["2021JJ41021"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693556"],"award-info":[{"award-number":["2021M693556"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Glaucoma is the leading cause of irreversible blindness. The progressive degeneration of retinal ganglion cells (RGCs) is the major characteristic of glaucoma. Even though the control of intraocular pressure could delay the loss of RGCs, current clinical treatments cannot protect them directly. The overactivation of N-methyl-D-aspartic acid (NMDA) receptors by excess glutamate (Glu) is among the important mechanisms of RGC death in glaucoma progression. Melatonin (MT) is an indole neuroendocrine hormone mainly secreted by the pineal gland. This study aimed to investigate the therapeutic effect of MT on glutamate excitotoxicity of mouse RGCs and R28 cells. The Glu-induced R28 cell excitotoxicity model and NMDA-induced retinal injury model were established. MT was applied to R28 cells and the vitreous cavity of mice by intravitreal injection. Cell counting kit-8 assay and propidium iodide\/Hoechst were performed to evaluate cell viability. Reactive oxygen species and glutathione synthesis assays were used to detect the oxidative stress state of R28 cells. Retina immunofluorescence and hematoxylin and eosin staining were applied to assess RGC counts and retinal structure. Flash visual-evoked potential was performed to evaluate visual function in mice. RNA sequencing of the retina was performed to explore the underlying mechanisms of MT protection. Our results found that MT treatment could successfully protect R28 cells from Glu excitotoxicity and decrease reactive oxygen species. Also, MT rescued RGCs from NMDA-induced injury and protected visual function in mice. This study enriches the indications of MT in the treatment of glaucoma, providing practical research ideas for its comprehensive prevention and treatment.<\/jats:p>","DOI":"10.3389\/fendo.2022.986131","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:19:15Z","timestamp":1665551955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells"],"prefix":"10.3389","volume":"13","author":[{"given":"Chao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2016.10.001","article-title":"Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma","volume":"56","author":"De Moraes","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ophtha.2021.08.025","article-title":"The effect of achieving target intraocular pressure on visual field worsening","volume":"129","author":"Villasana","year":"2022","journal-title":"Ophthalmology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2020.01.010","article-title":"Localization in glaucomatous visual field loss vulnerable to posture-induced intraocular pressure changes in open-angle glaucoma","volume":"213","author":"Manabe","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314322","article-title":"Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG longitudinal (CUPAL) study","volume":"104","author":"Cheung","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/s1350-9462(98)00031-7","article-title":"Glutamate receptors and circuits in the vertebrate retina","volume":"18","author":"Thoreson","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1385\/MN:34:3:163","article-title":"N-methyl-D-aspartate receptors in the retina","volume":"34","author":"Shen","year":"2006","journal-title":"Mol Neurobiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311193110","article-title":"Cytosolic reducing power preserves glutamate in retina","volume":"110","author":"Du","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01828.x","article-title":"VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina","volume":"89","author":"Teuchner","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","article-title":"Preservation of vision after CaMKII-mediated protection of retinal ganglion cells","volume":"184","author":"Guo","year":"2021","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a hormone: New physiological and clinical insights","volume":"39","author":"Cipolla-Neto","year":"2018","journal-title":"Endocr Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12360","article-title":"Melatonin as an antioxidant: under promises but over delivers","volume":"61","author":"Reiter","year":"2016","journal-title":"J Pineal Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2007.10.001","article-title":"Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues","volume":"27","author":"Wiechmann","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010527.pub2","article-title":"Melatonin for women in pregnancy for neuroprotection of the fetus","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41398-021-01464-x","article-title":"Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders","volume":"11","author":"Melhuish Beaupre","year":"2021","journal-title":"Transl Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12744","article-title":"Melatonin augments the neuroprotective effects of hypothermia in lambs following perinatal asphyxia","volume":"71","author":"Aridas","year":"2021","journal-title":"J Pineal Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2018.04.001","article-title":"The coma in glaucoma: Retinal ganglion cell dysfunction and recovery","volume":"65","author":"Fry","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173208","article-title":"Neuroprotection: A versatile approach to combat glaucoma","volume":"881","author":"Naik","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/ceo.13336","article-title":"Neuroprotection in glaucoma: recent advances and clinical translation","volume":"47","author":"Guymer","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e12730","DOI":"10.1111\/jpi.12730","article-title":"Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma","volume":"70","author":"Gubin","year":"2021","journal-title":"J Pineal Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.332149","article-title":"Melatonin, circadian rhythms and glaucoma: current perspective","volume":"17","author":"Gubin","year":"2022","journal-title":"Neural Regener Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12662","article-title":"Decreased melatonin secretion in patients with glaucoma: Quantitative association with glaucoma severity in the LIGHT study","volume":"69","author":"Yoshikawa","year":"2020","journal-title":"J Pineal Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(94)31332-7","article-title":"The effect of melatonin on aqueous humor flow in humans during the day","volume":"101","author":"Viggiano","year":"1994","journal-title":"Ophthalmology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13253","article-title":"Elevated intraocular pressure increases melatonin levels in the aqueous humour","volume":"95","author":"Alkozi","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181907ebe","article-title":"Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia","volume":"108","author":"Ismail","year":"2009","journal-title":"Anesth Analg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12189","article-title":"Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients","volume":"35","author":"Pescosolido","year":"2015","journal-title":"Ophthal Physiol Opt"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2012.12.009","article-title":"Melatonin analogue agomelatine reduces rabbit's intraocular pressure in normotensive and hypertensive conditions","volume":"701","author":"Martinez-Aguila","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12716","article-title":"Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia","volume":"71","author":"Huang","year":"2021","journal-title":"J Pineal Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2174\/1871527319666201012125149","article-title":"Melatonin alleviates pyroptosis of retinal neurons following acute intraocular hypertension","volume":"20","author":"Zhang","year":"2021","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e12676","DOI":"10.1111\/jpi.12676","article-title":"Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system","volume":"69","author":"NaveenKumar","year":"2020","journal-title":"J Pineal Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910896","article-title":"7,8-dihydroxiflavone protects adult rat axotomized retinal ganglion cells through MAPK\/ERK and PI3K\/AKT activation","volume":"22","author":"Galindo-Romero","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.21037\/atm-22-136","article-title":"Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K\/AKT signaling pathway via caveolin 1 upregulation","volume":"10","author":"Xi","year":"2022","journal-title":"Ann Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1954742","article-title":"Resveratrol acts via the mitogen-activated protein kinase (MAPK) pathway to protect retinal ganglion cells from apoptosis induced by hydrogen peroxide","volume":"12","author":"Ye","year":"2021","journal-title":"Bioengineered"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002218R","article-title":"Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma","volume":"35","author":"Yu","year":"2021","journal-title":"FASEB J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2001217","article-title":"Baicalin suppresses glaucoma pathogenesis by regulating the PI3K\/AKT signaling in vitro and in vivo","volume":"12","author":"Zhao","year":"2021","journal-title":"Bioengineered"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3378","article-title":"MicroRNA-145-5p targeting of TRIM2 mediates the apoptosis of retinal ganglion cells via the PI3K\/AKT signaling pathway in glaucoma","volume":"23","author":"Xu","year":"2021","journal-title":"J Gene Med"},{"key":"B39","article-title":"Intrinsically photosensitive retinal ganglion cells are resistant to n-methyl-D-aspartic acid excitotoxicity","volume":"18","author":"DeParis","year":"2012","journal-title":"Mol Vis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05718.x","article-title":"PI3K\/akt, JAK\/STAT and MEK\/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury","volume":"26","author":"Luo","year":"2007","journal-title":"Eur J Neurosci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu037","article-title":"Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK\/STAT signalling","volume":"137","author":"Vigneswara","year":"2014","journal-title":"Brain"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.986131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:19:20Z","timestamp":1665551960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.986131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":41,"alternative-id":["10.3389\/fendo.2022.986131"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.986131","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"article-number":"986131"}}